61. Recent advances with cyclin-dependent kinase inhibitors: therapeutic agents for breast cancer and their role in immuno-oncology. Issue 7 (3rd July 2019) Authors: Di Sante, Gabriele; Pagé, Jessica; Jiao, Xuanmao; Nawab, Omar; Cristofanilli, Massimo; Skordalakes, Emmanuel; Pestell, Richard G Journal: Expert review of anticancer therapy Issue: Volume 19:Issue 7(2019) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Recurrent granulomatous mastitis mimicking inflammatory breast cancer. (25th January 2011) Authors: Ergin, Ahmet Bahadir; Cristofanilli, Massimo; Daw, Hamed; Tahan, Gulgun; Gong, Yun Journal: BMJ case reports Issue: Volume 2011 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Relationship between Circulating Tumor Cells, Blood Coagulation, and Urokinase‐Plasminogen‐Activator System in Early Breast Cancer Patients. Issue 2 (27th January 2015) Authors: Mego, Michal; Karaba, Marian; Minarik, Gabriel; Benca, Juraj; Sedlácková, Tatiana; Tothova, Lubomira; Vlkova, Barbora; Cierna, Zuzana; Janega, Pavol; Luha, Jan; Gronesova, Paulina; Pindak, Daniel; Fridrichova, Ivana; Celec, Peter; Reuben, James M.; Cristofanilli, Massimo; Mardiak, Jozef Journal: Breast journal Issue: Volume 21:Issue 2(2015:Mar./Apr.) Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies. (November 2017) Authors: Roviello, Giandomenico; Andre, Fabrice; Venturini, Sergio; Pistilli, Barbara; Curigliano, Giuseppe; Cristofanilli, Massimo; Rosellini, Pietro; Generali, Daniele Journal: European journal of cancer Issue: Volume 86(2017) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer. Issue 10 (1st April 2023) Authors: Liedtke, Cornelia; Mazouni, Chafika; Hess, Kenneth R.; André, Fabrice; Tordai, Attila; Mejia, Jaime A.; Symmans, W. Fraser; Gonzalez-Angulo, Ana M.; Hennessy, Bryan; Green, Marjorie; Cristofanilli, Massimo; Hortobagyi, Gabriel N.; Pusztai, Lajos Journal: Journal of clinical oncology Issue: Volume 41:Issue 10(2023) Page Start: 1809 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Standard of Care in Hormone Receptor–Positive Metastatic Breast Cancer: Can We Improve the Current Regimens or Develop Better Selection Tools?. Issue 5 (15th May 2022) Authors: D'Amico, Paolo; Cristofanilli, Massimo Journal: JCO oncology practice Issue: Volume 18:Issue 5(2022) Page Start: 331 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer. Issue 3 (17th March 2022) Authors: Kunder, Ratika; Velyunskiy, Michelle; Dunne, Sara F.; Cho, Byoung-Kyu; Kanojia, Deepak; Begg, Lauren; Orriols, Adrienne M.; Fleming-Trujillo, Erica; Vadlamani, Pranathi; Vialichka, Alesia; Bolin, Rosemary; Perrino, Jessica N.; Roth, Diane; Clutter, Matthew R.; Zielinski-Mozny, Nicolette A.; Goo, ... Journal: Cell chemical biology Issue: Volume 29:Issue 3(2022) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Targeting Epidermal Growth Factor Receptor in triple negative breast cancer: New discoveries and practical insights for drug development. (February 2017) Authors: Costa, Ricardo; Shah, Ami N.; Santa-Maria, Cesar A.; Cruz, Marcelo R.; Mahalingam, Devalingam; Carneiro, Benedito A.; Chae, Young Kwang; Cristofanilli, Massimo; Gradishar, William J.; Giles, Francis J. Journal: Cancer treatment reviews Issue: Volume 53(2017) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. (February 2019) Authors: Cristofanilli, Massimo; Pierga, Jean-Yves; Reuben, James; Rademaker, Alfred; Davis, Andrew A.; Peeters, Dieter J.; Fehm, Tanja; Nolé, Franco; Gisbert-Criado, Rafael; Mavroudis, Dimitrios; Grisanti, Salvatore; Giuliano, Mario; Garcia-Saenz, Jose A.; Stebbing, Justin; Caldas, Carlos; Gazzaniga, Pao... Journal: Critical reviews in oncology/hematology Issue: Volume 134(2019) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells. (February 2020) Authors: Reduzzi, Carolina; Vismara, Marta; Gerratana, Lorenzo; Silvestri, Marco; De Braud, Filippo; Raspagliesi, Francesco; Verzoni, Elena; Di Cosimo, Serena; Locati, Laura D.; Cristofanilli, Massimo; Daidone, Maria Grazia; Cappelletti, Vera Journal: Seminars in cancer biology Issue: Volume 60(2020) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗